Cells (May 2022)

Functional Characterization of Endothelial Cells Differentiated from Porcine Epiblast Stem Cells

  • Joon-Hong Shin,
  • Bo-Gyeong Seo,
  • In-Won Lee,
  • Hyo-Jin Kim,
  • Eun-Chan Seo,
  • Kwang-Min Lee,
  • Soo-Been Jeon,
  • Sang-Ki Baek,
  • Tae-Suk Kim,
  • Jeong-Hyung Lee,
  • Jung-Woo Choi,
  • Cheol Hwangbo,
  • Joon-Hee Lee

DOI
https://doi.org/10.3390/cells11091524
Journal volume & issue
Vol. 11, no. 9
p. 1524

Abstract

Read online

Endothelial cells (ECs), lining blood vessels’ lumen, play an essential role in regulating vascular functions. As multifunctional components of vascular structures, pluripotent stem cells (PSCs) are the promising source for potential therapeutic applications in various vascular diseases. Our laboratory has previously established an approach for differentiating porcine epiblast stem cells (pEpiSCs) into ECs, representing an alternative and potentially superior cell source. However, the condition of pEpiSCs-derived ECs growth has yet to be determined, and whether pEpiSCs differentiate into functional ECs remained unclear. Changes in morphology, proliferation and functional endothelial marker were assessed in pEpiSCs-derived ECs in vitro. pEpiSCs-derived ECs were subjected to magnetic-activated cell sorting (MACS) to collect CD-31+ of ECs. We found that sorted ECs showed the highest proliferation rate in differentiation media in primary culture and M199 media in the subculture. Next, sorted ECs were examined for their ability to act as typical vascular ECs through capillary-like structure formation assay, Dil-acetylated low-density lipoprotein (Dil-Ac-LDL) uptake, and three-dimensional spheroid sprouting. Consequently, pEpiSCs-derived ECs function as typical vascular ECs, indicating that pEpiSC-derived ECs might be used to develop cell therapeutics for vascular disease.

Keywords